Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs Cefuroxime Axetil in Erythema Migrans
NCT03584919Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jun 2006
- Primary completion
- Sep 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Randomised, open-label trial of doxycycline and cefuroxime axetil in erythema migrans (EM), sponsored by University Medical Centre Ljubljana. Primary endpoint: Change from Baseline in Objective Manifestations and Subjective New or Increased Symptoms (NOIS) at 12 months. Started Jun 2006; status: completed.
02
Drugs
doxycyclinecefuroxime axetil
03
Conditions
erythema migrans (EM)
Beyond the preview
Go deeper on NCT03584919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03584919.